Risk Factors for Chronic Lung Disease and Mortality in Newborns with Congenital Diaphragmatic Hernia by Jongste-van den Hout, L. (Lieke) de et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Neonatology 2010;98:370–380 
 DOI: 10.1159/000316974 
 Risk Factors for Chronic Lung Disease and 
Mortality in Newborns with Congenital 
Diaphragmatic Hernia
 L. van den Hout   a     I. Reiss   a     J.F. Felix   b     W.C.J. Hop   c     Pamela A. Lally   d     
Kevin P. Lally   d     D. Tibboel   a     for the Congenital Diaphragmatic Hernia
Study Group
 a 
  Intensive Care and Department of Pediatric Surgery, Erasmus MC – Sophia,  b   Department of Epidemiology, 
Erasmus MC, and  c   Department of Biostatistics, Erasmus MC,  Rotterdam , The Netherlands;  d   Department of Pediatric 
Surgery, University of Texas Medical    School and Children’s Memorial Hermann Hospital,  Houston, Tex. , USA
 
anomaly, a chromosomal anomaly and a lower gestational 
age were all associated with BPD and/or mortality by day 30. 
 Conclusions: Despite improvements in neonatal care, the 
rates of BPD and early mortality in newborns with CDH are 
still considerable. Several important risk factors for a worse 
outcome are reported in this nonrandomized prospective 
observational study.  Copyright © 2010 S. Karger AG, Basel
 Introduction
 Congenital diaphragmatic hernia (CDH) is a rare con-
genital anomaly which occurs in approximately 1 in ev-
ery 2,500 live births  [1] . It is associated with severe pul-
monary hypoplasia and pulmonary hypertension. Mor-
tality rates ranging from 10 to 35% have been reported, 
depending on case selection  [1–5] . Survival rates have in-
creased with improvements in neonatal care, including 
 Key Words
 Congenital diaphragmatic hernia   Bronchopulmonary 
dysplasia   Neonatal mortality
 Abstract
 Background: Congenital diaphragmatic hernia (CDH) is as-
sociated with a mortality rate of 10–35% in live-born infants. 
Moreover, CDH survivors have a substantial risk of develop-
ing long-term pulmonary sequelae, such as bronchopulmo-
nary dysplasia (BPD).  Objectives: This study aims to evaluate 
risk factors associated with BPD and mortality in neonates 
with CDH, with particular focus on the initial ventilation 
mode.  Methods: Eligible for inclusion were live-born infants 
with CDH born from 2001 through 2006 at the centers par-
ticipating in the CDH Study Group. BPD (defined as oxygen 
dependency at day 30) and/or mortality by day 30 served as 
the primary endpoint.  Results: A total of 2,078 neonates 
were included in the analysis. At day 30, 56% of the patients 
had either died or met the criteria for BPD. In infants who 
survived until day 30, the prevalence of BPD was 41%. The 
overall mortality rate was 31%. High-frequency oscillatory 
ventilation as initial ventilation mode, a right-sided defect, a 
prenatal diagnosis, a lower Apgar score at 5 min, a cardiac 
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‘gentle’ ventilation strategies, delayed surgery and extra-
corporeal membrane oxygenation (ECMO) in selected 
cases  [4–8] . However, survivors of CDH remain at high 
risk of developing secondary morbidity. Long-term pul-
monary sequelae, such as chronic lung disease, persistent 
pulmonary hypertension, asthmatic symptoms and re-
current respiratory tract infections have been reported
in 30–50% of cases  [9–14] . Alarmed by this information, 
the American Academy of Pediatrics developed official 
guidelines for structural and interdisciplinary follow-up 
 [15] . 
 Bronchopulmonary dysplasia (BPD) is a chronic respi-
ratory disorder presenting early after birth. It mostly oc-
curs in premature infants or term infants who have acute 
pulmonary disease. Ventilator-induced lung injury and 
high concentrations of oxygen predispose newborns to 
develop BPD  [16, 17] . In newborns with CDH, the sever-
ity of lung hypoplasia may also be predictive for the de-
velopment of BPD  [13, 14, 18] . 
 Research efforts have been directed at optimizing ven-
tilation strategies for newborns with CDH. The ‘permis-
sive hypercapnia’ approach, for example, led to higher 
survival rates and less pulmonary morbidity  [5, 19] . 
Around the world, newborns with CDH typically receive 
conventional ventilation, with high-frequency oscillatory 
ventilation (HFO) as rescue therapy. However, in certain 
cases HFO will serve as the initial ventilation mode  [20] . 
Observational and retrospective studies have reported 
that HFO as an initial ventilation mode may be an effec-
tive method to reduce mortality and chronic lung disease 
in children with CDH  [7, 21–24] . So far, no prospective 
trials have been carried out to determine if initial ventila-
tion treatment with HFO may reduce long-term pulmo-
nary sequelae. Moreover, most studies so far have focused 
on mortality and the need for ECMO rather than on 
chronic lung disease as outcome measures  [9, 18, 25] . 
 The aim of this study is to describe possible risk factors 
for BPD and early mortality in infants with CDH. More 
specifically, this study aimed to determine if the initial 
ventilation mode, either conventional ventilation or 
HFO, has some bearing on outcome. 
 Methods 
 Patients
 We retrieved data from the large multi-institutional database 
of the CDH Study Group. This cooperative network of over 50 
centers was established in 1995 to compile data on live-born chil-
dren with CDH. Data on prenatal evaluation, mode of delivery, 
neonatal care, surgery and clinical outcome until hospital dis-
charge or death are prospectively recorded on standardized reg-
istry forms and entered into a central database  [26] . 
 In the CDH Registry database, data on the mode and duration 
of ventilation were available from the year 2001 until the year 
2006. Therefore, we only included children born between January 
2001 and December 2006. The large majority had been treated 
with conventional ventilation or HFO as initial ventilation mode. 
The few newborns treated with high-frequency jet ventilation 
were excluded from the analysis. Newborns with central or bilat-
eral CDH were excluded as well because their clinical course dif-
fers from that of those with more common left- or right-sided 
CDH  [27] . 
 For the purpose of this article, data from 64 centers were col-
lected. Centers are arbitrarily coded in the CDH Registry data-
base as ‘high-volume’ or ‘low-volume’ centers. High-volume cen-
ters are those that admit more than 10 newborns with CDH per 
year. Furthermore, centers were coded as ECMO centers or non-
ECMO centers. 
 The primary outcome measure in this study was BPD and/or 
mortality by day 30. In addition, separate analyses were per-
formed for mortality by day 30 and BPD. Jobe and Bancalari  [28] 
have defined BPD as oxygen dependency at day 28 or at 36 weeks 
postmenstrual age, depending on the gestational age at birth. 
However, the CDH Registry database holds data on oxygen de-
pendency at day 30 instead of day 28. This is why we used oxygen 
dependency at day 30 as the criterion for BPD. The severity of BPD 
is determined at day 56 or at discharge, whichever comes first  [28] . 
However, this could not be determined since data on oxygen de-
pendency at day 56 were not recorded in the CDH Registry. Data 
on oxygen dependency at discharge or transfer are presented in a 
descriptive way. 
 Statistical Analysis
 To test associations between individual putative risk factors 
and outcome measures, univariate analyses were performed, us-
ing   2  and Mann-Whitney U tests where appropriate. Baseline 
variables that showed a significant effect in univariate analysis 
were entered into multiple logistic regression analyses for BPD 
and/or mortality by day 30 and BPD and mortality by day 30 sep-
arately using a stepwise backward elimination method. p values 
for trend over the study years for all 3 outcome measures were also 
calculated using logistic regression. As many data on medication 
for pulmonary hypertension and the position of the liver were 
missing, we did not use these variables in the statistical analysis. 
Results of the regression analyses are given as odds ratios with the 
95% confidence interval. Data were analyzed using SPSS 16.0 
(SPSS Inc., Chicago, Ill., USA). A two-sided p value less than 0.05 
was considered statistically significant.
 Results
 The CDH database held data on 4,466 patients born 
from 1995 onwards. Eligible subjects were those born be-
tween 2001 and 2006, a total of 2,134 children. Of these, 
56 were excluded based on our exclusion criteria or incor-
rect data, leaving 2,078 subjects ( fig. 1 ). Analysis revealed 
no significant differences in baseline patient characteris-
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tics, the prevalence of BPD (p = 0.762) or the survival rate 
(p = 0.122) between the patients included in the study and 
patients who were born before 2001 (n = 2,120). BPD and/
or mortality by day 30 was present in 56% (n = 1,116/2,003, 
missing data = 75) of the included patients and 58% (n = 
1,162/2,012, missing data = 8) of the nonincluded patients 
who were born before 2001 (p = 0.144). Patient character-
istics are shown in  table 1 .
 BPD and Mortality by Day 30
 By day 30, 56% of all the study infants (n = 1,116/2,003, 
missing data = 75) had either died or met the criteria for 
BPD. Mortality by day 30 was 24% (n = 492/2,078). Over-
all mortality until hospital discharge for all 2,078 new-
borns was 31% (n = 634/2,078). Of the newborns that sur-
vived until day 30, 41% (n = 624/1,511, missing data = 75) 
met the criteria for BPD. Of these infants, 56% (n = 
344/612, missing data = 12) had mechanical ventilation, 
9% (n = 57/612) had continuous positive airway pressure 
and 34% (n = 211/612) had a nasal cannula at day 30. Of 
the infants that survived, 21% (n = 304/1,423, missing 
data = 21) were oxygen dependent at discharge or trans-
fer. Of these, 17% (n = 51/295, missing data = 11) were 
mechanically ventilated at discharge or transfer, 2% (n = 
6/295) received continuous positive airway pressure and 
81% (n = 238/295) had a nasal cannula. 
 The prevalence of BPD and/or death by day 30 did not 
change over the study period (p for trend = 0.251). The 
prevalences of mortality by day 30 and BPD separately 
also did not change significantly over the study period
(p for trend = 0.625 and 0.317, respectively). 
 Extracorporeal Membrane Oxygenation
 A total of 1,910 infants were born in an ECMO center. 
Overall, an ECMO procedure was performed in 29% of 
the patients (n = 595/2,078). The median day on which 
ECMO was started was the second day of life (range 
Total patients in CDH Registry
n = 4,466
Patients born between 2001 and 2006
n = 2,134*
Included patients 
n = 2,078
Patients died at or before day 30
n = 492
No BPD
n = 887
BPD***
n = 624
Excluded patients**
n = 56
 Fig. 1. Flowchart of patient inclusion and 
exclusion in the present study.  *  2,120 pa-
tients were born before 2001; 212 patients 
were born after 2006.  **  Due to bilateral 
CDH (n = 13), central CDH (n = 4), high-
frequency jet ventilation (n = 13) or incor-
rect data on survival (n = 26).  ***  Data on 
BPD were missing for 75 patients. 
 Table 1.  Baseline characteristics for all live-born patients with 
CDH (n = 2,078) born between 2001 and 2006
 Variable  Number of
 patients 
 % 
 Males  1,235/2,076  59 
 Birth in high-volume center  1,132/2,078  54 
 Birth in ECMO center  1,910/2,078  92 
 Inborn 837/2,076  40 
 Vaginal delivery  1,021/1,855  55 
 Prenatal diagnosis  1,246/2,073  60 
 Cardiac abnormality 322/2,077  16 
 Chromosomal abnormality 89/2,077 4 
 Other abnormality 1 176/2,078 8 
 Left-sided defect  1,735/2,060  84 
 Continuous variables  Median  Range  
 Gestational age at birth, weeks  38 23–42 
 Birth weight, kg 3.03  0.57–4.90 
 Apgar score at 5 min 7 0–10 
 N umbers do not always add up to 2,078 because of missing 
data.
 1  Other abnormality is classified as a congenital anomaly oth-
er than congenital heart disease or a chromosomal abnormality. 
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0–129). The median duration of the ECMO treatment was 
10 days (range 0–42). A total of 283 patients (48%) had 
surgical correction of the diaphragmatic defect during 
the ECMO treatment.
 A total of 93% infants (n = 523/564, missing data = 31) 
who underwent an ECMO procedure had either died by 
day 30 or met the criteria for BPD, compared with 41% of 
the infants (n = 591/1,439, missing data = 44) who did not 
undergo an ECMO procedure (p  ! 0.001). By day 30, 38% 
of the patients who underwent an ECMO procedure had 
died (n = 212/564, missing data = 31), compared to 19% 
(n = 280/1,483) of the patients who did not undergo an 
ECMO procedure (p  ! 0.001). Overall mortality after an 
ECMO procedure was 51% (n = 285/564, missing data = 
31). BPD was present in 88% of the patients who under-
went an ECMO procedure and survived until day 30 (n = 
311/352), compared to 27% of the patients who did not 
undergo an ECMO procedure and survived until day 30 
(n = 313/1,159; p  ! 0.001).
 Surgical Repair
 A surgical repair was performed in 83% of all patients 
(n = 1,729/2,078). The median day of surgical repair was 
the fourth day of life (range 0–112). A patch repair, as op-
posed to primary repair, was performed in 49% of the 
cases (n = 837/1,725, missing data = 4). 
 Seventy-five percent of the infants (n = 599/801, miss-
ing data = 36) who underwent a patch repair had either 
died by day 30 or met the criteria for BPD, compared with 
20% of the infants (n = 171/854, missing data = 34) who 
did not undergo a patch repair (p  ! 0.001). Of the patients 
who underwent a patch repair, 16% (n = 132/837) had died 
by day 30, compared to 2% (n = 18/888) of the patients 
who underwent a primary repair (p  ! 0.001). BPD was 
present in 70% of the patients who underwent a patch
repair and survived until day 30 (n = 467/669, missing 
data = 36), compared to 18% of the patients who under-
went a primary repair and survived until day 30 (n = 
153/852, missing data = 34; p  ! 0.001). 
 Initial Ventilation Mode 
 Of all patients, 35% received HFO (n = 674/1,936) and 
65% received conventional ventilation (n = 1,262/1,936, 
missing data = 142) as initial ventilation mode. The me-
dian duration of ventilation in children initially treated 
with HFO was 17 days (range 1–199), compared to 11 days 
(range 0–741) in children treated with conventional ven-
tilation (p  ! 0.001).
 Table 2.  Baseline patient characteristics for patients with CDH who received initial ventilatory treatment with 
HFO (n = 674) or CMV (n = 1,261)
 Variable  HFO  % CMV  % p value 
 Males  391/674  58 753/1,260  60 0.485 
 Birth in high-volume center  398/674  59 708/1,262  56 0.230 
 Birth in ECMO center  651/674  96  1,144/1,262  91  <0.001 
 Inborn  360/674  53 422/1,260  33  <0.001 
 Vaginal delivery  312/588  53 665/1,161  57 0.104 
 Prenatal diagnosis  480/674  71 673/1,261  53  <0.001 
 Cardiac abnormality 93/674  14 203/1,261  16 0.203 
 Chromosomal abnormality 33/673 5 46/1,262 4 0.226 
 O ther abnormality 1 69/674  10 92/1,262 7 0.031 
 Left-sided defect  562/673  84  1,057/1,258  84 0.819 
 Continuous variables  Median  Range  Median  Range p value 
 Gestational age at birth, weeks  38 26–42  38 26–42 0.126 
 Birth weight, kg 3.0  0.6–4.9 3.1  0.7–4.8  <0.001 
 Apgar score at 5 min 7 1–9 7 0–10  <0.001 
 Nu mbers do not always add up to 1,935 because of missing data. CMV = Conventional mechanical ventila-
tion.
 1  Other abnormality is classified as a congenital anomaly other than congenital heart disease or a chromo-
somal abnormality. 
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 Differences in baseline patient characteristics between 
patients who initially received HFO or conventional ven-
tilation are presented in  table  2 . Patients who received 
HFO as the initial ventilation mode were significantly 
more often prenatally diagnosed (p  ! 0.001), inborn (i.e. 
born in a tertiary clinic; p  ! 0.001) and born in an ECMO 
center (p  ! 0.001), had significantly more other abnor-
malities (p = 0.031) and had a significantly lower median 
birth weight (p  ! 0.001) and Apgar score at 5 min (p  ! 
0.001). 
 Patients who received initial treatment with HFO had 
BPD and/or died by day 30 significantly more often than 
patients who received initial treatment with conventional 
ventilation (p  ! 0.001; data shown in  tables 3 and  4 ).  
 Of the infants who initially received HFO, 39% (n = 
260/674) underwent an ECMO procedure, compared 
with 23% (n = 296/1,262) of the infants who initially re-
ceived conventional ventilation (p  ! 0.001). In total, 526 
patients who initially received HFO and 1,100 patients 
who initially received conventional ventilation under-
went a surgical repair. Of those patients, 64% of the pa-
tients who were initially treated with HFO (n = 336/524, 
missing data = 2) underwent a patch repair, as opposed to 
primary closure, compared with 40% (n = 441/1,098, 
missing data = 2) of patients treated with conventional 
ventilation as initial ventilation mode (p  ! 0.001). 
 Multivariate Analysis 
 The univariate analyses of baseline variables for BPD 
and/or mortality by day 30 are presented in  table 3 . Sepa-
rate univariate analyses for BPD and mortality by day 30 
are presented in  table 4 . Baseline variables that were sig-
nificant were entered into multiple logistic regression 
analyses for all 3 outcome measures. Variables regarding 
surgical repair and ECMO therapy were not entered into 
the multivariate analyses, because we only included those 
variables that were known at baseline. 
 As data on the method of delivery were missing for 223 
patients, we excluded this variable from the multivariate 
analyses. Birth weight and gestational age were both sig-
nificant in the univariate analyses, but due to their high 
correlation with each other, only gestational age was add-
ed to the multivariate analysis. 
 The baseline variables location of birth (in- or out-
born, i.e. not in a tertiary clinic), birth in an ECMO cen-
ter (yes or no), prenatal diagnosis, cardiac abnormality, 
chromosomal abnormality, side of the defect (left or right 
side), Apgar score at 5 min, the initial mode of ventilation 
and gestational age were all entered in the multivariate 
analyses for early mortality and BPD. 
 The results of the final multivariate analyses are shown 
in  tables 5 ,  6 and  7 . A lower gestational age, a cardiac 
anomaly, a chromosomal anomaly, a prenatal diagnosis, 
a right-sided defect, a lower Apgar score at 5 min and 
 Table 3.  Univariate analyses of baseline variables for patients born 
between 2001 and 2006 who had BPD and/or had died by day 30 
(n = 1,116, missing data = 75)
 Variable  BPD and/or death
 by day 30 
 % p value 
 Gender 0.160 
 Male 649/1,192  58 
 Female 467/809  58 
 Volume of center 0.085 
 High 521/900  58 
 Low 595/1,103  54 
 Birth in ECMO center 0.006 
 Yes  1,040/1,836  57 
 No 76/167  46 
 Birth location  <0.001 
 Inborn 534/812  66 
 Outborn 582/1,189  49 
 Method of delivery  <0.001 
 Cesarean section 496/807  61 
 Vaginal delivery 499/985  51 
 Prenatal diagnosis  <0.001 
 Yes  802/1,204  67 
 No 310/794  39 
 Cardiac abnormality  <0.001 
 Yes 242/312  78 
 No 874/1,690  52 
 Chromosomal abnormality  <0.001 
 Yes 78/87  90 
 No  1,037/1,915  54 
 Other abnormality 1 1.000 
 Yes 94/169  56 
 No  1,022/1,834  56 
 Side of defect  <0.001 
 Left 879/1,667  53 
 Right 229/328  70 
 Initial ventilation mode  <0.001 
 HFO 460/632  73 
 CMV 564/1,233  46 
 Continuous variables  Median (range)  p value 
 Gestational age, weeks 6 (0–10)  <0.001 
 Birth weight, kg 2.93 (0.57–4.80)  <0.001 
 Apgar score at 5 min 38 (23–42)  <0.001 
 N umbers do not always add up to 1,116 because of missing 
data. CMV = Conventional mechanical ventilation.
 1  Other abnormality is classified as a congenital anomaly oth-
er than congenital heart disease or a chromosomal abnormality. 
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HFO as initial ventilation mode were associated with a 
higher risk of BPD and/or death by day 30. Having a chro-
mosomal anomaly was also associated with early mortal-
ity, but not with BPD. Additionally, being inborn was as-
sociated with a higher risk of mortality by day 30, and 
being outborn was associated with a higher risk of BPD. 
 Although we did not include variables that were not 
known at baseline, we did test for various interactions 
between these variables and the baseline variables. In this 
regard, we found an interaction between the need for 
ECMO treatment and the initial mode of ventilation in 
the multivariate analyses for BPD and/or death by day 30 
 Table 4.  Univariate analyses of baseline variables for patients born between 2001 and 2006 who had BPD
(n = 624) or who had died by day 30 (n = 492)
 Variable  BPD  % p value  Death by day 30  % p value 
 Gender     0.420     0.150 
 Male  370/913  41    279/1,235  23 
 Female  254/596  43    213/841  25 
 Volume of center     0.071     0.398 
 High  303/690  44    276/1,132  24 
 Low  321/821  39    236/946  25 
 Birth in ECMO center  <0.001 0.016 
 Yes  601/1,397  43  439/1,910  23 
 No  23/114  20  53/168  32 
 Birth location      <0.001      <0.001 
 Inborn  260/538  48    274/837  33 
 Outborn  364/971  37    218/1,239  18 
 Method of delivery     0.007      <0.001 
 Cesarean section  255/566  45    241/834  29 
 Vaginal delivery  294/780  38    205/1,021  20 
 Prenatal diagnosis      <0.001      <0.001 
 Yes   434/836  52    368/1,246  30 
 No  188/672  28    122/827  15 
 Cardiac abnormality      <0.001      <0.001 
 Yes  127/197  64    115/322  36 
 No  497/1,313  38    377/1,755  21 
 Chromosomal abnormality      <0.001      <0.001 
 Yes  23/32  72    55/89  62 
 No  601/1,479  41    436/1,988  22 
 O ther abnormality 1     0.445     0.241 
 Yes  46/121  38    48/176  27 
 No  578/1,390  42    444/1,902  23 
 Side of defect      <0.001     0.001 
 Left  497/1,285  39    382/1,735  22 
 Right  127/226  56    102/335  30 
 Initial ventilation mode      <0.001      <0.001 
 HFO  229/401  57    231/674  34 
 CMV  346/1,015  34    218/1,262  17 
 Continuous variables  Median (range)      Median (range)     
 Gestational age, weeks  38 (23–42)    <0.001  38 (26–42)    <0.001 
 Birth weight, kg  3.00 (0.64–4.8)    <0.001  2.79 (0.57–4.48)    <0.001 
 Apgar score at 5 min  7 (0–10)  <0.001  6 (0–9)  <0.001 
 Nu mbers do not always add up to 624 and 492 because of missing data. CMV = Conventional mechanical 
ventilation.
 1  Other abnormality is classified as a congenital anomaly other than congenital heart disease or a chromo-
somal abnormality. 
 
 
 van den Hout   et al. Neonatology 2010;98:370–380 376
and BPD alone. This revealed that in patients who under-
went an ECMO procedure, the initial mode of ventilation 
was no longer associated with these outcome measures.
 Also, we found an interaction between the location of 
birth and HFO as initial ventilation mode. In patients 
who were born outside a tertiary clinic, HFO was still as-
sociated with a higher risk of BPD and/or death by day 30 
and BPD alone. In patients who were born in a tertiary 
clinic, HFO gave a slightly higher risk of BPD and/or 
death by day 30 and BPD alone. However, this was not 
significant because the confidence intervals overlapped. 
 We did not find any interactions between birth in an 
ECMO center, the volume of the center and the initial 
ventilation mode. Also, we did not find any variables that 
modified the effect of HFO in the analysis for early mor-
tality.
 Discussion 
 In this study, 56% of all the infants included had either 
died or met the criteria for BPD at day 30. In survivors of 
CDH, BPD, with a prevalence of 41%, remains an impor-
tant clinical issue. Moreover, the prevalence of BPD and/
or early mortality remained constant over the years of the 
study period, despite promising advances in neonatal 
care and urgent reports from centers around the world. 
Unexpectedly, this study showed that initial ventilatory 
treatment with HFO was associated with worse postnatal 
outcome. 
 We can propose several causes for the high prevalence 
of BPD. Firstly, these children’s hypoplastic lungs may be 
more susceptible to oxygen toxicity than the lungs of oth-
er newborns with respiratory distress  [12] . Moreover, 
maldevelopment of the pulmonary vasculature may con-
tribute to pulmonary hypertension, which in itself in-
creases morbidity and mortality in BPD  [29] . Thirdly, the 
asymmetry of the lungs may result in areas of differential 
compliance and the subsequent risk of overexpansion of 
the alveoli  [12, 13] . Fourthly, although centers mostly use 
gentle ventilation strategies nowadays, aggressive venti-
lation strategies with high peak inspiratory pressures 
cannot always be avoided. Subsequent volutrauma, baro-
trauma and atelectrauma may contribute to significant 
 Table 5. M ultivariate logistic regression analysis of BPD and/or 
death by day 30 (n = 1,686)
 Variable  OR  95% CI p value 
 Gestational age in weeks  0.84  0.81–0.90  <0.001 
 Cardiac abnormality  2.62  1.85–3.72  <0.001 
 Chromosomal abnormality  3.04  1.42–6.51 0.004 
 Prenatal diagnosis  3.90  3.00–5.00  <0.001 
 Right-sided defect  2.76  1.96–3.89  <0.001 
 Apgar score at 5 min  0.61  0.57–0.65  <0.001 
 HFO as initial ventilation mode  2.53  1.95–3.27  <0.001 
 N onsignificant variables in the multivariate analysis: birth in 
ECMO center (odds ratio 1.39, 95% confidence interval 0.80–2.44; 
p = 0.244) and location of birth (odds ratio 1.1, 95% confidence 
interval 0.83–1.46; p = 0.487). OR = Odds ratio; CI = confidence 
interval. 
 
 
 Table 6. M ultivariate logistic regression analysis for BPD (n = 
1,293)
 Variable  OR  95% CI p value 
 Gestational age in weeks  0.87  0.82–0.92  <0.001 
 Cardiac abnormality  2.42  1.85–3.67  <0.001 
 Inborn  0.70  0.52–0.95 0.023 
 Prenatal diagnosis  4.27  3.05–5.80  <0.001 
 Right-sided defect  2.51  1.73–3.64  <0.001 
 Apgar score at 5 min  0.66  0.61–0.71  <0.001 
 HFO as initial ventilation mode  2.29  1.73–3.04  <0.001 
 N onsignificant variables in the multivariate analysis: birth in 
ECMO center (odds ratio 1.81, 95% confidence interval 0.94–3.48; 
p = 0.074) and having a chromosomal abnormality (odds ratio 
1.37, 95% confidence interval 0.57–3.26; p = 0.480). OR = Odds 
ratio; CI = confidence interval. 
 
 
 Table 7. M ultivariate logistic regression analysis for mortality by 
day 30 (n = 1,749)
 Variable  OR  95% CI p value 
 Gestational age in weeks  0.87  0.83–0.92  <0.001 
 Cardiac abnormality  1.54  1.11–2.14 0.010 
 Chromosomal abnormality  4.49  2.63–7.67  <0.001 
 Inborn   1.76  1.30–2.38  <0.001 
 Prenatal diagnosis  1.80  1.28–2.02  <0.001 
 Right-sided defect  1.88  1.35–2.63  <0.001 
 Apgar score at 5 min  0.68  0.64–0.73  <0.001 
 HFO as initial ventilation mode  1.85  1.42–2.41  <0.001 
 N onsignificant variable in the multivariate analysis: birth in 
ECMO center (odds ratio 0.71, 95% confidence interval 0.37–1.34; 
p = 0.286). OR = Odds ratio; CI = confidence interval. 
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pulmonary injury, including diffuse alveolar damage, 
hyaline membrane formation and intra-alveolar hemor-
rhage  [23, 30] . 
 This study suggests that HFO as the initial ventilation 
mode is a risk factor for BPD and/or mortality by day 30 
and for BPD and mortality separately. This was a some-
what surprising finding because previous retrospective 
and observational studies indicated that HFO as the ini-
tial ventilation mode might be an effective method to in-
crease survival and reduce BPD in newborns with CDH 
 [21, 22, 24] . It was thought to ameliorate ventilation-in-
duced lung injury by promoting uniform lung inflation, 
reducing barotrauma and suppressing inflammatory me-
diators  [23, 30–33] . On the other hand, HFO might well 
cause lung hyperinflation. The resultant higher alveolar 
and mean airway pressures would then raise the risk of 
pulmonary barotrauma and hemodynamic instability, 
due to adverse effects on venous return and pulmonary 
vascular resistance  [23] . 
 A possible explanation for the association between 
HFO as the initial ventilation mode and BPD as well as 
early mortality might be that the infants who initially 
received HFO were more severely ill from the start. 
Compared with those patients who received conven-
tional ventilation initially, patients who received HFO 
as initial treatment had a significantly lower Apgar score 
at 5 min and a lower birth weight. Patients who received 
HFO were more often inborn and prenatally diagnosed 
compared with infants who received conventional ven-
tilation. HFO was also associated with a significantly 
longer duration of ventilation compared with conven-
tional ventilation. Furthermore, patients who received 
initial treatment with HFO underwent an ECMO pro-
cedure more often. Moreover, they more often had a 
patch repair, which might be associated with a larger 
defect size and more severe pulmonary hypoplasia. 
Therefore, we may speculate that these infants’ condi-
tion was worse than that of infants on conventional ven-
tilation from the start.
 In this regard, it is unfortunate that some variables 
that might have given an indication of the severity of dis-
ease could not be included in the multivariate analyses 
because they were not known at baseline. However, we 
did test for various interactions between variables. In this 
regard, we found that in patients who underwent an 
ECMO procedure, the initial mode of ventilation was no 
longer associated with BPD and/or death by day 30 and 
BPD alone. Also, HFO gave only a slightly higher risk of 
BPD and/or death by day 30 and BPD alone in patients 
who were born in a tertiary clinic. Moreover, we did not 
find any variables that modified the effect of HFO in the 
analysis for early mortality. Baseline data on prenatal pre-
dictors of outcome, such as the lung-to-head ratio, were 
not available. It may, for example, be speculated that fe-
tuses with a lower lung-to-head ratio and a possible worse 
outcome may have been treated initially with HFO. 
 A right-sided defect was associated with a higher risk 
of BPD and/or early mortality and BPD and early mortal-
ity separately. This is in line with previous studies, which 
reported a higher risk of mortality and worse outcome in 
patients with right-sided defects  [34, 35] . 
 Furthermore, a prenatal diagnosis was another impor-
tant risk factor for BPD and/or early mortality and BPD 
and early mortality separately. Infants who are diagnosed 
prenatally are more likely to have more obvious anoma-
lies and a more severe herniation visible on ultrasound, 
which may explain this higher risk of a worse outcome. 
However, prenatal detection of the diaphragmatic defect 
in infants with CDH may be dependent on the quality of 
obstetric care and prenatal screening. 
 A low Apgar score at 5 min of life was also associated 
with a higher risk of a worse outcome. This is in line with 
a previous study by the CDH Study Group, which report-
ed that the Apgar score at 5 min predicted mortality in 
newborns with CDH  [36] . Furthermore, a cardiac abnor-
mality, a chromosomal anomaly and a lower gestational 
age were also associated with worse outcome. 
 Being inborn, i.e. in a tertiary clinic, was a risk factor 
for early mortality in this study. This may be explained 
by the fact that mortality is not always reported in preg-
nancy terminations, stillbirths and outborn children who 
die shortly after birth  [37] . As a consequence, the mortal-
ity rate for inborn children with CDH may be relatively 
higher. However, it must be taken into account that the 
study centers in the CDH Registry use different referral 
policies. 
 This study did not show an association between the 
volume of the center and postnatal outcome. However, a 
previous study reported higher survival rates in high-vol-
ume centers, defined as more than 6 patients with CDH 
admitted per year  [38] . This difference may be explained 
by the fact that we used a different cutoff to define the 
volume of the center. Also, no association was found be-
tween postnatal outcome and birth in an ECMO center. 
In the multivariate analysis, no associations were found 
between birth in an ECMO center, birth in a high-volume 
center and the initial ventilation mode. More specific 
data on the type of center and the treatment protocols 
they used are lacking, since all centers are anonymously 
coded in the CDH Registry. Differences between the var-
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ious centers may therefore still play a role in outcome in 
infants with CDH, although we were not able to find such 
an association in this study. 
 This study showed that gender was not a risk factor for 
worse outcome in newborns with CDH. Studies in pre-
term infants reported boys to be at higher risk for BPD 
and mortality in general  [39, 40] . As newborns with CDH 
are usually born at term, the above-mentioned associa-
tion reported for premature infants may not be fully ap-
plicable to them.
 Although ECMO could not be included in the multi-
variate analysis, because it is not a baseline characteris-
tic, ECMO was associated with a higher risk of BPD and 
early mortality in univariate analyses. Patients with 
CDH who need ECMO therapy are likely to have severe 
pulmonary hypoplasia and pulmonary hypertension, 
resulting in a higher risk of worse outcome. Mortality 
after an ECMO procedure was 51%, which is comparable 
to previous studies and data from the Extracorporeal 
Life Support Organization registry  [41, 42] . The role of 
ECMO in the treatment of infants with CDH is still un-
clear  [43] . However, in nonrandomized trials, ECMO 
has been reported to improve survival in infants with 
CDH  [44, 45] . 
 This is the first study to describe chronic lung disease 
and its risk factors in a large number of patients with 
CDH. However, its possible limitations should not go un-
mentioned. For one, some important data could not be 
determined, such as disease severity, pulmonary hyper-
tension, the position of the liver, the severity of BPD and 
prenatal predictors of outcome. Therefore, additional re-
search should be performed taking into account the full 
spectrum of the disease. Moreover, patients who received 
HFO underwent an ECMO procedure more often, and 
the association between BPD and/or death by day 30 and 
BPD alone and the initial ventilation mode was not shown 
in infants who received ECMO therapy. Therefore, con-
founding by indication may have biased our results. Fur-
thermore, selection bias could have occurred because 
only data from hospitals participating in the CDH Study 
Group were retrieved. In addition, these hospitals used 
different treatment protocols and referral policies, which 
may have influenced outcomes. In this regard, oxygen 
dependency was not defined according to standard prac-
tice in our study centers. A previous study by Walsh et al. 
 [46] reported a lower incidence of BPD if oxygen depen-
dency was confirmed by a room air challenge test. Since 
data on room air challenge tests were not available in our 
study, our results may have been biased. 
 Conclusion
 BPD and mortality in newborns with CDH remain 
important problems, despite improvements in neonatal 
care. Moreover, BPD may lead to long-term pulmonary 
morbidity. HFO has been heralded as a promising venti-
lation treatment to reduce mortality and pulmonary 
morbidity in CDH newborns. However, in the present 
study, initial ventilation treatment with HFO was associ-
ated with a higher risk of a worse outcome. Nonetheless, 
the results of this study must be interpreted with caution, 
because selection bias and confounding by indication 
may have occurred. Therefore, further prospective stud-
ies are needed to study risk factors and optimal ventila-
tion strategies in children with CDH. In addition, stan-
dardized treatment protocols and follow-up guidelines, 
such as those developed by the American Academy of Pe-
diatrics in 2008, should be implemented as crucial ways 
to improve healthcare in children with CDH  [15] . This 
calls for extensive collaboration between centers with ex-
pertise in the treatment of newborns with CDH, such as 
the CDH Euro-Consortium, which recently initiated the 
VICI trial, a randomized controlled trial on ventilation 
strategies in infants with CDH (www.vicitrial.com). 
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